“Drugs on oxygen”: an update and perspective on the role of cytochrome P450 testing in pharmacology

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.8, Iss.11, 2012-11, pp. : 1357-1362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update

By Anglicheau Dany Legendre Christophe Beaune Philippe Thervet Eric

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 835-849

Future Medicine

Access to resources Recommend Favorite

Cytochrome P450 and Anticancer Drugs

Current Drug Metabolism, Vol. 7, Iss. 1, 2006-01 ,pp. : 23-37

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

By Zanger Ulrich Raimundo Sebastian Eichelbaum Michel

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 23-37

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric Legendre Christopher Beaune Philippe Anglicheau Dany

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

Inflammation, reactive oxygen species and cytochrome P450

By Symons Andrew M. King Laurence J.

Inflammopharmacology, Vol. 11, Iss. 1, 2003-02 ,pp. : 75-86

VSP

Access to resources Recommend Favorite